A detailed history of Strs Ohio transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Strs Ohio holds 6,200 shares of RYTM stock, worth $304,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,200
Previous 13,600 54.41%
Holding current value
$304,110
Previous $589,000 56.88%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$35.41 - $44.37 $262,033 - $328,338
-7,400 Reduced 54.41%
6,200 $254,000
Q1 2024

May 13, 2024

BUY
$39.12 - $52.44 $414,672 - $555,864
10,600 Added 353.33%
13,600 $589,000
Q4 2023

Jan 30, 2024

BUY
$21.39 - $49.64 $64,170 - $148,920
3,000 New
3,000 $137,000
Q1 2023

Aug 02, 2023

BUY
$16.88 - $34.24 $237,991 - $482,749
14,099 New
14,099 $251,000
Q1 2023

Apr 27, 2023

BUY
$16.88 - $34.24 $237,991 - $482,749
14,099 New
14,099 $251,000
Q1 2020

Apr 23, 2020

SELL
$13.16 - $22.9 $31,584 - $54,960
-2,400 Closed
0 $0
Q4 2017

Jan 23, 2018

BUY
$22.0 - $30.51 $52,800 - $73,224
2,400
2,400 $69,000

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $2.73B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.